Can Combination Therapies Benefit from Formulation Changes?
Yes, combination therapies can significantly benefit from formulation changes. By co-formulating multiple drugs into a single delivery system, researchers can achieve synergistic effects, reduce the risk of drug resistance, and improve patient compliance. An example is the co-encapsulation of chemotherapeutic agents with immunomodulators to enhance the anti-cancer immune response.
